"Deglutition Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
Descriptor ID |
D003680
|
MeSH Number(s) |
C06.405.117.119 C09.775.174
|
Concept/Terms |
Deglutition Disorders- Deglutition Disorders
- Deglutition Disorder
- Disorders, Deglutition
- Swallowing Disorders
- Swallowing Disorder
- Dysphagia
|
Below are MeSH descriptors whose meaning is more general than "Deglutition Disorders".
Below are MeSH descriptors whose meaning is more specific than "Deglutition Disorders".
This graph shows the total number of publications written about "Deglutition Disorders" by people in this website by year, and whether "Deglutition Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Deglutition Disorders" by people in Profiles.
-
Oesophageal tuberculosis with concomitant candidiasis: a rare cause of dysphagia. BMJ Case Rep. 2019 Nov 02; 12(11).
-
Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol. 2010 Dec; 97(3):488-94.
-
Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy. 2004; 3(4):191-5.
-
Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1998 Jan 15; 40(2):447-53.
-
Palliation of carcinoma of the oesophagus with brachytherapy and the Didcott dilator. Ann R Coll Surg Engl. 1996 Mar; 78(2):124-8.